Acquiring Company
Centaurus
Acquired Company
Oncoclínicas
Description
Centaurus has launched a takeover bid for Oncoclínicas, potentially reaching R$14 billion. This move, ordered by Brazil's CVM, marks a significant transaction in the capital markets. Oncoclínicas, currently undergoing restructuring, could see its market capitalization impacted by the bid. The offer is set to be extended to all shareholders within a mandated timeline.
Don't miss Centaurus's next move
Get an email the moment Centaurus makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Oncoclínicas?
Oncoclínicas was acquired by Centaurus, based in United States. The deal was reported on August 28, 2026. Centaurus is a U.S. asset management firm known for its significant investments in various sectors. It focuses on achieving high returns through strategic acquisitions and investment opportunities. Centaurus is privately held and operates in Financial Services.
When did Centaurus acquire Oncoclínicas?
Centaurus's acquisition of Oncoclínicas was reported on August 28, 2026. Centaurus has launched a takeover bid for Oncoclínicas, potentially reaching R$14 billion. This move, ordered by Brazil's CVM, marks a significant transaction in the capital markets. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Oncoclínicas do?
Oncoclínicas is a network of cancer clinics that specializes in oncology services. The company has faced significant financial challenges over the past three years due to aggressive expansion and rising interest rates. It is privately held, operating in Financial Services.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.